Zivo Bioscience, Inc.
ZIVO· OTC
Filed Aug 14, 2012 · 10-Q · 45 days after period end · 0001078782-12-002001
| Metric | Q2 2012 | Q2 2011 | Q2 2010 |
|---|---|---|---|
| Revenue | $0.00 | $27.86K | $19.12K |
| Net Income | -$748.55K | -$313.18K | -$21.67K |
| EPS Diluted | -$0.01 | $0.00 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Zivo Bioscience, Inc. · CIK 1101026 · Engraved from SEC EDGAR
ended Jun 30, 2012 · filed Aug 14, 2012 · 45 d after period end